Seegene, Inc. is a leading developer of multiplex molecular diagnostics (MDx) products that detect multiple numbers of pathogens simultaneously in a single reaction.

Seegene’s proprietary DPO™ (Dual Priming Oligonucleotide), READ™ (Real Amplicon Detection) and TOCE™ technologies adapted to its products allow faster and more reliable diagnosis at lower costs.

An innovative diagnostic product called “Seeplex® RV ACE Detection” from Seegene, Inc. detects 12 different respiratory pathogens simultaneously with maximized specificity and sensitivity, promoting most appropriate treatments while reducing unnecessary antibiotic administrations and hospitalizations.

It may be also used to identify and isolate infected patients to prevent nosocomial infection spread as well as for national surveillance screening – Currently, CDCs in 23 provinces in China and some of state-governmental testing centers operate year-round surveillance system with Seegene’s RV products.

This product is now approved in 30 countries (including Canada and EU) as an IVD (in vitro diagnostics) and undergoing the process for FDA clearance along with Seegene’s other major products for an accelerated penetration into US market which accounts for almost 50% of total molecular diagnostics market.

Seegene offers a wide range of products, including Respiratory virus, TB/MDR, A/B/C Hepatitis, STI, Sepsis, Cervical Cancer, Meningitis, acute Gastrointestinal, and somatic mutations including Drug-resistant bacteria, Thyroid cancer, Leukemia and Genetic mutations both through its own global distribution network and also its partnership with global companies.

Seegene has been selected as one of the world’s 30 molecular diagnostic dompanies by various global medical market research institutes, including Kalorama Information, Research and Markets.

Until now, Seegene has won a total of 15 awards from the Korean government branches and civil evaluation organizations such as Jang Young Shil Award (the Ministry of Education, Science and Technology), New Growth Engine grand prize (the Ministry of Knowledge Technology), Healthcare Industry Technology prize (the Ministry of Health and Welfare), and Hidden Champion company(KRX).

Currently, Seegene is vigorously exporting its items to 37 global markets, including the U.S.A, Japan, the UK, Brazil, Germany, France, Italy, Spain, India, China, etc. Seegene, founded in Seoul, Korea in 2000, has subsidiaries in Gaithersburg, MD, U.S.A. and in Eschborn, Germany.

• Seegene, Inc.
Fl. 7, Taewon Bldg., 65-5, Bangyi-dong, Songpa-gu, Seoul, Korea
Tel: (82-2)2240-4033
Fax: (82-2) 2240-4040
Website: seegene.com